Pantoprazole and Orgaran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pantoprazole (pantoprazole sodium) and Orgaran (danaparoid sodium). Common drug interactions include aspartate aminotransferase increased among females and heparin-induced thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Pantoprazole and Orgaran. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,170 Pantoprazole users. Check the latest studies of Pantoprazole.

What is Orgaran?

Orgaran has active ingredients of danaparoid sodium. eHealthMe is studying from 863 Orgaran users. Check the latest studies of Orgaran.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 02, 2026

29 people who take Pantoprazole and Orgaran together, and have interactions are studied.

Pantoprazole and Orgaran drug interactions.

What are the common drug interactions of Pantoprazole and Orgaran, by gender? *:

female:

Aspartate aminotransferase increased
Colitis ulcerative (inflammation of colon with ulcer)
Cytomegalovirus viraemia (cytomegalo virus in blood stream)
Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
Herpes virus infection
Pancreatitis (inflammation of pancreas)
Rectal haemorrhage (bleeding from anus)
Cross sensitivity reaction
Exfoliative rash (scaly red generalized skin rash)
Anaphylactoid shock (serious allergic reaction that is rapid in onset and may cause death)

male:

Heparin-induced thrombocytopenia
Skin mass
Thrombocytopenia (decrease of platelets in blood)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

What are the common drug interactions of Pantoprazole and Orgaran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Pancreatitis (inflammation of pancreas)
Anaphylactoid shock (serious allergic reaction that is rapid in onset and may cause death)
Blood amylase increased
Cardiogenic shock (inadequate circulation of blood)
Hepatic enzyme increased
Leukopenia (less number of white blood cells in blood)
Lipase increased
Thrombocytopenia (decrease of platelets in blood)

40-49:

Death

50-59:

Febrile neutropenia (fever with reduced white blood cells)

60+:

Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Acute generalised exanthematous pustulosis (acute febrile drug eruption)
Cross sensitivity reaction
Exfoliative rash (scaly red generalized skin rash)
Heparin-induced thrombocytopenia
Skin exfoliation (removal of the oldest dead skin cells)
Skin mass
Thrombocytopenia (decrease of platelets in blood)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Pyrexia (fever)

What are the existing conditions these people have? *

Lung Disorder (lung disease): 9 people, 31.03%
Rashes (redness): 8 people, 27.59%
Pain: 8 people, 27.59%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 13.79%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 4 people, 13.79%
Heparin-Induced Thrombocytopenia: 2 people, 6.90%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and Orgaran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously